Literature DB >> 1259917

Letter: Digoxin does not prevent daunorubicin or adriamycin from binding to rat heart muscle.

B J Smith, D Kundv.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1259917      PMCID： PMC2024933          DOI： 10.1038/bjc.1976.30

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  4 in total

1.  A clinicopathologic analysis of adriamycin cardiotoxicity.

Authors:  E A Lefrak; J Pitha; S Rosenheim; J A Gottlieb
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

2.  Daunorubicin in acute myelocytic leukaemia.

Authors:  J S Malpas; R B Scott
Journal:  Lancet       Date:  1969-03-01       Impact factor: 79.321

3.  Management of adult acute myelogenous leukaemia.

Authors:  D Crowther; R L Powles; C J Bateman; M E Beard; C L Gauci; P F Wrigley; J S Malpas; G H Fairley; R B Scott
Journal:  Br Med J       Date:  1973-01-20

4.  Clinical trials with adriamycin.

Authors:  E Middleman; J Luce; E Frei
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860
  4 in total
  2 in total

Review 1.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

2.  The effect of digoxin on the binding of adriamycin to cat heart muscle.

Authors:  J Somberg; N Cagin; H Bovnous; B Levitt
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.